Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Health concerns for hiv exposed but non infected children.

Fiore JR, Di Stefano M, Faleo G, Bruno S, Santantonio T, Greco P.

Minerva Ginecol. 2020 Mar 17. doi: 10.23736/S0026-4784.20.04520-7. [Epub ahead of print] No abstract available.

PMID:
32186167
2.

Effectiveness of switching to darunavir/cobicistat in virologically-suppressed HIV-positive patients receiving ritonavir-boosted protease inhibitor-based regimen: the "STORE" Study.

Gori A, Antinori A, Vergori A, Cossu MV, Menzaghi B, Sterrantino G, Rusconi S, Cattelan A, Castelli F, Gianotti N, Orofino G, Ripamonti D, Savinelli S, Manzillo E, Santantonio TA, Celesia BM, Cauda R, Maserati R, Dʼarminio Monforte A, Stingone C, Bonora S, Uglietti A, Termini R, Rucci F, Mancusi D.

J Acquir Immune Defic Syndr. 2020 Feb 24. doi: 10.1097/QAI.0000000000002331. [Epub ahead of print]

PMID:
32101882
3.

The absence of culturable bacteria from at term placentae from HIV-negative and positive women argues against a placental unique microbiota.

Fiore JR, Di Stefano M, Greco P, Elnour MO, Alwazzeh MJ, Santantonio T.

Minerva Ginecol. 2019 Dec;71(6):476-477. doi: 10.23736/S0026-4784.19.04474-5. Epub 2019 Nov 13. No abstract available.

PMID:
31741368
4.

Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.

Brancaccio G, Fasano M, Grossi A, Santantonio TA, Gaeta GB.

Aliment Pharmacol Ther. 2019 Apr;49(8):1071-1076. doi: 10.1111/apt.15188. Epub 2019 Feb 21.

PMID:
30793345
5.

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.

Calvaruso V, Mazzarelli C, Milazzo L, Badia L, Pasulo L, Guaraldi G, Lionetti R, Villa E, Borghi V, Carrai P, Alberti A, Biolato M, Piai G, Persico M, Santantonio T, Felder M, Angelico M, Montalbano M, Mancusi RL, Grieco A, Angeli E, D'Offizi G, Fagiuoli S, Belli L, Verucchi G, Puoti M, Craxì A.

Sci Rep. 2019 Jan 24;9(1):585. doi: 10.1038/s41598-018-36734-0.

6.

Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.

Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, D'Angelo S, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Mod Rheumatol. 2019 Nov;29(6):895-902. doi: 10.1080/14397595.2018.1558918. Epub 2019 Jan 22. Erratum in: Mod Rheumatol. 2019 Apr 2;:1.

PMID:
30582388
7.

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.

Viganò M, Loglio A, Labanca S, Zaltron S, Castelli F, Andreone P, Messina V, Ganga R, Coppola N, Marrone A, Russello M, Marzano A, Tucci A, Taliani G, Fasano M, Fagiuoli S, Villa E, Bronte F, Santantonio T, Brancaccio G, Occhipinti V, Facchetti F, Grossi G, Rumi M, Lampertico P.

Liver Int. 2019 Mar;39(3):484-493. doi: 10.1111/liv.14017. Epub 2019 Jan 7.

PMID:
30525275
8.

Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry.

Esposito S, De Simone G, Pan A, Brambilla P, Gattuso G, Mastroianni C, Kertusha B, Contini C, Massoli L, Francisci D, Priante G, Libanore M, Bicocchi R, Borgia G, Maraolo AE, Brugnaro P, Panese S, Calabresi A, Amendola G, Savalli F, Geraci C, Tedesco A, Fossati S, Carretta A, Santantonio T, Cenderello G, Crisalli MP, Schiaroli E, Rovere P, Masini G, Ferretto R, Cascio A, Colomba C, Gioè C, Tumbarello M, Losito AR, Foti G, Prestileo T, Buscemi C, Chiara I, Iacobello C, Sonia S, Starnini G, Ialungo A, Sapienza M; Italian Society of Infectious and Tropical Diseases.

J Chemother. 2019 Feb;31(1):9-14. doi: 10.1080/1120009X.2018.1536320. Epub 2018 Dec 3.

PMID:
30508410
9.

Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.

Seto WK, Asahina Y, Brown TT, Peng CY, Stanciu C, Abdurakhmanov D, Tabak F, Nguyen TT, Chuang WL, Inokuma T, Ikeda F, Santantonio TA, Habersetzer F, Ramji A, Lau AH, Suri V, Flaherty JF, Wang H, Gaggar A, Subramanian GM, Mukewar S, Brunetto MR, Fung S, Chan HL.

Clin Gastroenterol Hepatol. 2018 Jun 20. pii: S1542-3565(18)30633-5. doi: 10.1016/j.cgh.2018.06.023. [Epub ahead of print]

PMID:
29933096
10.

Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

Kondili LA, Robbins S, Blach S, Gamkrelidze I, Zignego AL, Brunetto MR, Raimondo G, Taliani G, Iannone A, Russo FP, Santantonio TA, Zuin M, Chessa L, Blanc P, Puoti M, Vinci M, Erne EM, Strazzabosco M, Massari M, Lampertico P, Rumi MG, Federico A, Orlandini A, Ciancio A, Borgia G, Andreone P, Caporaso N, Persico M, Ieluzzi D, Madonia S, Gori A, Gasbarrini A, Coppola C, Brancaccio G, Andriulli A, Quaranta MG, Montilla S, Razavi H, Melazzini M, Vella S, Craxì A; PITER Collaborating Group.

Liver Int. 2018 Dec;38(12):2190-2198. doi: 10.1111/liv.13901. Epub 2018 Aug 10.

11.

Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays.

Gencay M, Seffner A, Pabinger S, Gautier J, Gohl P, Weizenegger M, Neofytos D, Batrla R, Woeste A, Kim HS, Westergaard G, Reinsch C, Brill E, Thuy PTT, Hoang BH, Sonderup M, Spearman CW, Brancaccio G, Fasano M, Gaeta GB, Santantonio T, Kaminski WE.

J Viral Hepat. 2018 Oct;25(10):1132-1138. doi: 10.1111/jvh.12915. Epub 2018 Jun 7.

PMID:
29660206
12.

Preliminary Data From the Study of Coagulative Profile of HIV Infected Individuals Suggest a Role For Point Mutations in the Gene in Protein S Deficiency in Individuals Undergoing Highly Antiretroviral Therapy.

Di Stefano M, D'Andrea G, Zoboli F, Faleo G, Fasano M, Martinelli D, Margaglione M, Santantonio TA, Fiore JR.

Open AIDS J. 2018 Feb 28;12:6-10. doi: 10.2174/1874613601812010006. eCollection 2018.

13.

Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A; ITAL-C consortium.

United European Gastroenterol J. 2018 Mar;6(2):225-237. doi: 10.1177/2050640617717158. Epub 2017 Jun 20.

14.

Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.

Gaeta GB, Puoti M, Coppola N, Santantonio T, Bruno R, Chirianni A, Galli M.

Infection. 2018 Apr;46(2):183-188. doi: 10.1007/s15010-017-1107-z. Epub 2017 Dec 13. Review.

PMID:
29238918
15.

Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.

Tartaglia A, Ferrara SM, Sica S, Santantonio T.

AIDS. 2017 Oct 23;31(16):2314-2315. doi: 10.1097/QAD.0000000000001623. No abstract available.

PMID:
28991029
16.

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.

Kondili LA, Gaeta GB, Brunetto MR, Di Leo A, Iannone A, Santantonio TA, Giammario A, Raimondo G, Filomia R, Coppola C, Amoruso DC, Blanc P, Del Pin B, Chemello L, Cavalletto L, Morisco F, Donnarumma L, Rumi MG, Gasbarrini A, Siciliano M, Massari M, Corsini R, Coco B, Madonia S, Cannizzaro M, Zignego AL, Monti M, Russo FP, Zanetto A, Persico M, Masarone M, Villa E, Bernabucci V, Taliani G, Biliotti E, Chessa L, Pasetto MC, Andreone P, Margotti M, Brancaccio G, Ieluzzi D, Borgia G, Zappulo E, Calvaruso V, Petta S, Falzano L, Quaranta MG, Weimer LE, Rosato S, Vella S, Giannini EG.

PLoS One. 2017 Oct 4;12(10):e0185728. doi: 10.1371/journal.pone.0185728. eCollection 2017.

17.

A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study.

Barone M, Iannone A, Shahini E, Ippolito AM, Brancaccio G, Morisco F, Milella M, Messina V, Smedile A, Conti F, Gatti P, Santantonio T, Tundo P, Lauletta G, Napoli N, Masetti C, Termite AP, Francavilla R, Di Leo A, Pesce F, Andriulli A.

J Viral Hepat. 2018 Jan;25(1):56-62. doi: 10.1111/jvh.12765. Epub 2017 Aug 30.

PMID:
28787102
18.

Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.

Kondili LA, Romano F, Rolli FR, Ruggeri M, Rosato S, Brunetto MR, Zignego AL, Ciancio A, Di Leo A, Raimondo G, Ferrari C, Taliani G, Borgia G, Santantonio TA, Blanc P, Gaeta GB, Gasbarrini A, Chessa L, Erne EM, Villa E, Ieluzzi D, Russo FP, Andreone P, Vinci M, Coppola C, Chemello L, Madonia S, Verucchi G, Persico M, Zuin M, Puoti M, Alberti A, Nardone G, Massari M, Montalto G, Foti G, Rumi MG, Quaranta MG, Cicchetti A, Craxì A, Vella S; PITER Collaborating Group.

Hepatology. 2017 Dec;66(6):1814-1825. doi: 10.1002/hep.29399. Epub 2017 Oct 30.

19.

Correlation between knowledge on transmission and prevention of HIV/STI and proficiency in condom use among male migrants from Africa and Middle East evaluated by a Condom Use Skills score using a wooden penile model.

Zoboli F, Martinelli D, Di Stefano M, Fasano M, Prato R, Santantonio TA, Fiore JR.

BMC Res Notes. 2017 Jun 19;10(1):216. doi: 10.1186/s13104-017-2520-1.

20.

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis.

Sebastiani M, Atzeni F, Milazzo L, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, Olivieri I, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Uberti Foppa C, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Manfredi A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Joint Bone Spine. 2017 Oct;84(5):525-530. doi: 10.1016/j.jbspin.2017.05.013. Epub 2017 May 18. Review.

PMID:
28529116
21.

HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fontanella L, Lauletta G, Cuccorese G, Metrangolo A, Francavilla R, Ciracì E, Rizzo S, Andriulli A.

Dig Liver Dis. 2017 Sep;49(9):1022-1028. doi: 10.1016/j.dld.2017.03.025. Epub 2017 Apr 8.

22.

Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.

Gencay M, Hübner K, Gohl P, Seffner A, Weizenegger M, Neofytos D, Batrla R, Woeste A, Kim HS, Westergaard G, Reinsch C, Brill E, Thu Thuy PT, Hoang BH, Sonderup M, Spearman CW, Pabinger S, Gautier J, Brancaccio G, Fasano M, Santantonio T, Gaeta GB, Nauck M, Kaminski WE.

PLoS One. 2017 May 4;12(5):e0172101. doi: 10.1371/journal.pone.0172101. eCollection 2017.

23.

Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients.

Fasano M, Maggi P, Leone A, Volpe A, Fiore JR, Angarano G, Santantonio TA.

Dig Liver Dis. 2017 May;49(5):530-534. doi: 10.1016/j.dld.2017.01.140. Epub 2017 Jan 16.

PMID:
28179096
24.

Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

Raghwani J, Rose R, Sheridan I, Lemey P, Suchard MA, Santantonio T, Farci P, Klenerman P, Pybus OG.

PLoS Pathog. 2016 Sep 15;12(9):e1005894. doi: 10.1371/journal.ppat.1005894. eCollection 2016 Sep.

25.

Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.

Fiore JR, Zoboli F, Di Stefano M, Faleo G, Fasano M, Santantonio TA.

AIDS. 2016 Apr 24;30(7):1144-6. doi: 10.1097/QAD.0000000000001040. No abstract available.

PMID:
27028146
26.

Flares during long-term entecavir therapy in chronic hepatitis B.

Chi H, Arends P, Reijnders JG, Carey I, Brown A, Fasano M, Mutimer D, Deterding K, Oo YH, Petersen J, van Bommel F, de Knegt RJ, Santantonio TA, Berg T, Welzel TM, Wedemeyer H, Buti M, Pradat P, Zoulim F, Hansen BE, Janssen HL; VIRGIL Surveillance Study Group (European surveillance network for vigilance against viral resistance).

J Gastroenterol Hepatol. 2016 Nov;31(11):1882-1887. doi: 10.1111/jgh.13377.

PMID:
27008918
27.

HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.

Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T.

Hepatol Int. 2015 Jan;9(1):52-7. doi: 10.1007/s12072-014-9556-2. Epub 2014 Aug 13.

28.

Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.

Maggi P, Montinaro V, Leone A, Fasano M, Volpe A, Bellacosa C, Grattagliano V, Coladonato L, Lapadula G, Santantonio T, Angarano G.

J Antimicrob Chemother. 2015 Apr;70(4):1150-4. doi: 10.1093/jac/dku502. Epub 2014 Dec 18.

PMID:
25525197
29.

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.

New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.

30.

Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance.

Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A.

Liver Int. 2014 Oct;34(9):1369-77. doi: 10.1111/liv.12411. Epub 2013 Dec 23.

PMID:
25283962
31.

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.

Arends P, Sonneveld MJ, Zoutendijk R, Carey I, Brown A, Fasano M, Mutimer D, Deterding K, Reijnders JG, Oo Y, Petersen J, van Bömmel F, de Knegt RJ, Santantonio T, Berg T, Welzel TM, Wedemeyer H, Buti M, Pradat P, Zoulim F, Hansen B, Janssen HL; VIRGIL Surveillance Study Group.

Gut. 2015 Aug;64(8):1289-95. doi: 10.1136/gutjnl-2014-307023. Epub 2014 Jul 10.

PMID:
25011935
32.

Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT).

Bruno R, Carosi G, Coppola N, Gaeta GB, Puoti M, Santantonio T, Taliani G, Armignacco O, Sagnelli E, Andreoni M, Angarano G, Di Perri G, D'Offizi G, Galli M, Rizzardini G; Italian Society for the Study of Infectious and Tropical Diseases.

Infection. 2014 Oct;42(5):811-5. doi: 10.1007/s15010-014-0642-0. Epub 2014 Jul 6. Review.

PMID:
24997980
33.

Chronic hepatitis B: Advances in treatment.

Santantonio TA, Fasano M.

World J Hepatol. 2014 May 27;6(5):284-92. doi: 10.4254/wjh.v6.i5.284. Review.

34.

Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery.

Leone P, Di Tacchio M, Berardi S, Santantonio T, Fasano M, Ferrone S, Vacca A, Dammacco F, Racanelli V.

J Hepatol. 2014 Aug;61(2):242-51. doi: 10.1016/j.jhep.2014.04.007. Epub 2014 Apr 13.

PMID:
24732300
35.

Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.

Sagnelli E, Santantonio T, Coppola N, Fasano M, Pisaturo M, Sagnelli C.

Infection. 2014 Aug;42(4):601-10. doi: 10.1007/s15010-014-0608-2. Epub 2014 Mar 12. Review.

PMID:
24619833
36.

Reply: To PMID 24442928.

Santantonio TA, Fasano M, Sagnelli E.

Hepatology. 2014 Dec;60(6):2129. doi: 10.1002/hep.27100. Epub 2014 Sep 23. No abstract available.

PMID:
24585448
37.

Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.

Santantonio T, Fasano M, Sagnelli E, Tundo P, Babudieri S, Fabris P, Toti M, Di Perri G, Marino N, Pizzigallo E, Angarano G; Acute Hepatitis C Study Group.

Hepatology. 2014 Jun;59(6):2101-9. doi: 10.1002/hep.26991. Epub 2014 Apr 29.

PMID:
24442928
38.

Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.

Di Marco V, Covolo L, Calvaruso V, Levrero M, Puoti M, Suter F, Gaeta GB, Ferrari C, Raimondo G, Fattovich G, Santantonio T, Alberti A, Bruno R, Mussini C, Mondelli M, Donato F, Craxì A; Multicenter Italian Group for the Study of Hepatitis C.

J Viral Hepat. 2013 Nov;20(11):790-800. doi: 10.1111/jvh.12106. Epub 2013 Sep 15.

PMID:
24168258
39.

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.

Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L, Sanguinetti M, Masciari R, Santantonio T, Andreoni S, Barchiesi F, Pecile P, Farina C, Viale P, Specchia G, Caggiano G, Pagano L.

Infection. 2014 Feb;42(1):141-51. doi: 10.1007/s15010-013-0539-3. Epub 2013 Oct 23.

40.

Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin.

Andriulli A, Di Marco V, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate ML, Mazzella G, Gaeta GB, Craxi A, Santantonio T.

J Hepatol. 2014 Jan;60(1):16-21. doi: 10.1016/j.jhep.2013.07.040. Epub 2013 Aug 20.

41.

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database.

Seaton RA, Malizos KN, Viale P, Gargalianos-Kakolyris P, Santantonio T, Petrelli E, Pathan R, Heep M, Chaves RL.

J Antimicrob Chemother. 2013 Jul;68(7):1642-9. doi: 10.1093/jac/dkt067. Epub 2013 Mar 20.

42.

Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, Gaeta GB, Angarano G, Verucchi G, Bellissima P, Angeletti C, Santantonio T.

Infection. 2013 Feb;41(1):53-9. doi: 10.1007/s15010-012-0384-9. Epub 2012 Dec 21.

PMID:
23264094
43.

Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy.

Antonucci G, Mazzotta F, Puoti M, Angeletti C, Girardi E, Santantonio T, Ambu S, Gaeta GB, Colucci M, Angarano G, Marino N, Rinaldi R, Bellissima P, Armignacco O, Carosi G, Sagnelli E; Coorte Epatiti B SIMIT (COESI-B) Group.

J Viral Hepat. 2012 Dec;19(12):881-9. doi: 10.1111/j.1365-2893.2012.01615.x. Epub 2012 May 10.

PMID:
23121367
44.

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years.

Fasano M, Lampertico P, Marzano A, Di Marco V, Niro GA, Brancaccio G, Marengo A, Scotto G, Brunetto MR, Gaeta GB, Rizzetto M, Angarano G, Santantonio T.

J Hepatol. 2012 Jun;56(6):1254-8. doi: 10.1016/j.jhep.2012.01.022. Epub 2012 Feb 16.

PMID:
22343167
45.

Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.

Missale G, Pilli M, Zerbini A, Penna A, Ravanetti L, Barili V, Orlandini A, Molinari A, Fasano M, Santantonio T, Ferrari C.

Gut. 2012 Jul;61(7):1076-84. doi: 10.1136/gutjnl-2011-300515. Epub 2012 Feb 15.

PMID:
22337949
46.

[Management of infections from cardiac implantable electronic devices: recommendations from a study panel].

Durante Mangoni E, Carbonara S, Iacobello C, Tripodi MF, Carretta A, Caprioli V, Pellegrino P, Di Biase M, Favale S, Santantonio TA, Esposito S, Nappi G, Angarano G, Utili R.

Infez Med. 2011 Dec;19(4):207-23. Review. Italian.

47.

Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α.

Scagnolari C, Trombetti S, Soldà A, Milella M, Gaeta GB, Angarano G, Scotto G, Caporaso N, Morisco F, Cozzolongo R, Giannelli G, Fasano M, Santantonio T, Antonelli G.

Clin Microbiol Infect. 2012 Oct;18(10):1033-9. doi: 10.1111/j.1469-0691.2011.03729.x. Epub 2011 Dec 22.

48.

Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological response.

Zoutendijk R, Reijnders JG, Brown A, Zoulim F, Mutimer D, Deterding K, Petersen J, Hofmann WP, Buti M, Santantonio T, van Bömmel F, Pradat P, Oo Y, Luetgehetmann M, Berg T, Hansen BE, Wedemeyer H, Janssen HL; VIRGIL Surveillance Study Group.

Hepatology. 2011 Aug;54(2):443-51. doi: 10.1002/hep.24406. Erratum in: Hepatology. 2011 Dec;54(6):2280.

PMID:
21563196
49.

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

Fattovich G, Covolo L, Bibert S, Askarieh G, Lagging M, Clément S, Malerba G, Pasino M, Guido M, Puoti M, Gaeta GB, Santantonio T, Raimondo G, Bruno R, Bochud PY, Donato F, Negro F; ITAHEC Study Group.

Aliment Pharmacol Ther. 2011 May;33(10):1162-72. doi: 10.1111/j.1365-2036.2011.04635.x. Epub 2011 Mar 28.

50.

Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.

Carosi G, Rizzetto M, Alberti A, Cariti G, Colombo M, Craxì A, Filice G, Levrero M, Mazzotta F, Pastore G, Piccinino F, Prati D, Raimondo G, Sagnelli E, Toti M, Brunetto M, Bruno R, Di Marco V, Ferrari C, Gaeta GB, Lampertico P, Marzano A, Pollicino T, Puoti M, Santantonio T, Smedile A.

Dig Liver Dis. 2011 Apr;43(4):259-65. doi: 10.1016/j.dld.2010.10.014. Epub 2011 Jan 26. Review.

PMID:
21276760

Supplemental Content

Loading ...
Support Center